Physician profile
Mark E Esterle
NPI 1003954876
$19,437.18
in general payments reported to CMS, 2019-2025
55 companies · $4,328 in 2025
The $4,328 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $1,448 · 2021: $1,909 · 2022: $2,152 · 2023: $5,979 · 2024: $2,278 · 2025: $4,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,043 · Education: $3,140 · Travel and Lodging: $2,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,043.49 |
| Education | $3,139.71 |
| Travel and Lodging | $2,402.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,409.14 | 2023-2025 | Ion, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,407.78 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,271.70 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals Lp | $1,256.65 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Pfizer INC. | $1,117.75 | 2019-2025 | |
| Insmed, INC. | $743.54 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $737.97 | 2019-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $680.09 | 2019-2025 | Dupixent, Libtayo |
| Actelion Pharmaceuticals US, INC. | $670.42 | 2019-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $653.90 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $628.86 | 2019-2024 | Yupelri |
| Genzyme Corporation | $539.75 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $411.10 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| Csl Behring | $328.99 | 2019-2025 | Kcentra |
| Genentech USA, INC. | $326.40 | 2019-2023 | Xolair |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $305.96 | 2021-2025 | Tezspire, Tavneos |
| Jazz Pharmaceuticals INC. | $266.76 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $265.18 | 2020-2023 | Glassia |
| Mallinckrodt Hospital Products INC. | $214.21 | 2021-2025 | Acthar |
| Sunovion Pharmaceuticals INC. | $201.50 | 2019-2020 | |
| Electromed, INC. | $193.05 | 2019-2024 | Smartvest |
| Verona Pharma, INC. | $171.58 | 2025 | Ohtuvayre |
| Pharming Healthcare, INC. | $118.36 | 2023-2024 | Ruconest |
| Janssen Pharmaceuticals, INC | $118.17 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $117.44 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.22 | 2019-2025 | |
| Pulmonx Corporation | $109.77 | 2021-2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Baxter Healthcare | $94.61 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $83.17 | 2020-2022 | |
| Viatris Specialty LLC | $72.94 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $71.36 | 2021-2024 | |
| Ani Pharmaceuticals, INC. | $65.63 | 2023-2024 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $61.92 | 2020-2021 | |
| Shire North American Group INC | $60.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $54.67 | 2019-2023 | Camzyos, Eliquis |
| Chiesi USA, INC. | $49.18 | 2019-2023 | Cleviprex |
| Mallinckrodt Enterprises LLC | $47.11 | 2019 | |
| Paratek Pharmaceuticals, INC. | $45.93 | 2021-2023 | Nuzyra |
| Cmp Pharma, INC. | $40.51 | 2023 | Tadliq |
| Avadel Cns Pharmaceuticals, LLC | $35.90 | 2023-2024 | Lumryz |
| Fisher & Paykel Healthcare INC | $28.58 | 2019-2025 | Fisher & Paykel Healthcare |
| Siemens Medical Solutions USA, INC. | $26.45 | 2024 | Cios Spin |
| Gilead Sciences, INC. | $24.48 | 2019 | |
| Breas Medical, INC. | $22.44 | 2025 | Vivo 45 Ls |
| Abbott Laboratories | $20.86 | 2022 | |
| Axsome Therapeutics, INC. | $19.73 | 2023 | Sunosi |
| Circassia INC. | $18.62 | 2019 | |
| Abbvie INC. | $16.26 | 2022 | |
| Mayne Pharma Commercial LLC | $15.80 | 2022 | |
| Advanced Respiratory, INC | $15.53 | 2021 | |
| Ambu INC. | $14.65 | 2023 | |
| Azurity Pharmaceuticals, INC. | $13.89 | 2023 | Horizant |
| Astellas Pharma US INC | $13.68 | 2019 | |
| Allergan, INC. | $13.12 | 2020 | |
| Philips North America LLC | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Esterle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.